Status:
UNKNOWN
Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Rhegmatogenous Retinal Detachment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized controlled trial comparing displacement of macula and the rapidity of reattachment of macula between two different positioning techniques after pneumatic retinopexy : Direct techn...
Detailed Description
Pneumatic retinopexy (PR) is an established treatment for rhegmatogenous retinal detachment (RRD). In our centre, PR is the most commonly performed procedure for primary RRD repair with a high retinal...
Eligibility Criteria
Inclusion
- Primary RRD
- Causative breaks over superior 8 clock hours
- Single break or group of breaks
- No or min proliferative vitreoretinopathy (PVR) (Grade A or B)
- Other breaks or lattice in attached retina are allowed
Exclusion
- Retinal break in the inferior 4 clock hours in detached retina
- PVR Grade C or worse
- Significant media opacity (Vitreous hemorrhage, dense cataract, cornea scar, etc)
- Pre-existing ocular pathology \[macula hole (MH), epiretinal membrane (ERM), cystoid macula edema (CME), age-related macula degeneration, myopic degeneration, advanced glaucoma, uveitis, amblyopia etc\] or previous eye trauma with poor baseline vision
- Previous pars plana vitrectomy
- Age ≤18years old
- Inadequate physical or mental competence to maintain the required postoperative head position
Key Trial Info
Start Date :
August 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 7 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04723420
Start Date
August 7 2020
End Date
December 7 2023
Last Update
April 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5